ReviewJ Gastrointest Oncol2022
Current update of treatment strategies for borderline resectable pancreatic cancer: a narrative review.
- Journal
- J Gastrointest Oncol
- Published
- 1 April 2022
- Citations
- 2
- Type
- Review
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Background and objective Borderline resectable pancreatic cancer (BRPC) is a tumor that infiltrates into the large blood vessels, with a high probability that the tumor will remain after surgical resection. To date, there has been no confirmed treatment strategy for BRPC. … Excerpt only: this text is the publisher’s. Read it in full at the source.